Abstract
The development of novel therapeutic strategies for glioma requires the identification of molecular targets involved in malignancy. Pygopus (Pygo) is a new discovered and specific downstream component of canonical Wnt signaling. Our previous study has demonstrated that Pygo2 is highly expressed in and promotes the growth of glioma cells. However, the role of Pygo2 in glioma remains to be elucidated. In the current study, we investigated the role of Pygo2 in human glioma U251 cells and showed that knocking down of the expression of Pygo2 in U251 cells using lentivirally expressed siRNA have inhibited cell proliferation and increased apoptosis through decreasing H3K4me3 expression. Moreover, we found Pygo2 was enriched in U251 glioma cancer stem-like cells and Pygo2 siRNA resulted in a reduced number as well as size of tumor spheres. According to our result, this paper now links mechanistically Pygo2’s role in histone modification to its enhancement/reduction of proliferation/apoptosis in glioma cells and indicate that Pygo2 may play an important role in self-renew and proliferation in U251 glioma cancer stem-like cells.
Similar content being viewed by others
Abbreviations
- CNS:
-
Central nervous system
- LEF/TCF:
-
Lymphoid-enhancing factor 1/T-cell factor
- H3K4me3:
-
Trimethylation of histone H3 at lysine 4
- EGF:
-
Epidermal growth factor
- bFGF:
-
Basic fibroblast growth factor
- GFP:
-
Green fluorescent protein
- GAPDH:
-
Glyceraldehyde-3-phosphate dehydrogenase
- TUNEL:
-
Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling
- DAPI:
-
4′,6-diamidino-2-phenylindole
References
Andrews PG, Lake BB, Popadiuk C, Kao KR (2007) Requirement of Pygopus 2 in breast cancer. Int J Oncol 30:357–363
Andrews PG, He Z, Popadiuk C, Kao KR (2009) The transcriptional activity of Pygopus is enhanced by its interaction with cAMP-response-element-binding protein (CREB)-binding protein. Biochem J 422:493–501. doi:10.1042/BJ20090134
Belenkaya TY, Han C, Standley HJ, Lin X, Houston DW, Heasman J (2002) Pygopus encodes a nuclear protein essential for wingless/Wnt signaling. Development 129:4089–4101
Bienz M (2006) The PHD finger, a nuclear protein-interaction domain. Trends Biochem Sci 31:35–40. doi:10.1016/j.tibs.2005.11.001
Chen J, Luo Q, Yuan Y, Huang X, Cai W, Li C, Wei T, Zhang L, Yang M, Liu Q, Ye G, Dai X, Li B (2010) Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion. Mol Cell Biol 30:5621–5635. doi:10.1128/MCB.00465-10
Cruceru ML, Neagu M, Demoulin JB, Constantinescu SN (2013) Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms. J Cell Mol Med 17:1218–1235. doi:10.1111/jcmm.12122
Fiedler M, Sanchez-Barrena MJ, Nekrasov M, Mieszczanek J, Rybin V, Muller J, Evans P, Bienz M (2008) Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex. Mol Cell 30:507–518. doi:10.1016/j.molcel.2008.03.011
Gu B, Sun P, Yuan Y, Moraes RC, Li A, Teng A, Agrawal A, Rheaume C, Bilanchone V, Veltmaat JM, Takemaru K, Millar S, Lee EY, Lewis MT, Li B, Dai X (2009) Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. J Cell Biol 185:811–826. doi:10.1083/jcb.200810133
Gu B, Watanabe K, Dai X (2012) Pygo2 regulates histone gene expression and H3 K56 acetylation in human mammary epithelial cells. Cell Cycle 11:79–87. doi:10.4161/cc.11.1.18402
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512
Jessen S, Gu B, Dai X (2008) Pygopus and the Wnt signaling pathway: a diverse set of connections. Bioessays 30:448–456. doi:10.1002/bies.20757
Kessler R, Hausmann G, Basler K (2009) The PHD domain is required to link Drosophila Pygopus to legless/beta-catenin and not to histone H3. Mech Dev 126:752–759. doi:10.1016/j.mod.2009.04.003
Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Zullig S, Basler K (2002) Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 109:47–60
Li B, Mackay DR, Ma J, Dai X (2004) Cloning and developmental expression of mouse pygopus 2, a putative Wnt signaling component. Genomics 84:398–405. doi:10.1016/j.ygeno.2004.04.007
Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD, Patel DJ (2006) Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 442:91–95. doi:10.1038/nature04802
Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108:837–847
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–408. doi:10.1006/meth.2001.1262
Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810. doi:10.1146/annurev.cellbio.20.010403.113126
Modrek AS, Bayin NS, Placantonakis DG (2014) Brain stem cells as the cell of origin in glioma. World J Stem Cells 6:43–52. doi:10.4252/wjsc.v6.i1.43
Nair M, Nagamori I, Sun P, Mishra DP, Rheaume C, Li B, Sassone-Corsi P, Dai X (2008) Nuclear regulator Pygo2 controls spermiogenesis and histone H3 acetylation. Dev Biol 320:446–455. doi:10.1016/j.ydbio.2008.05.553
Niwa H (2007) Open conformation chromatin and pluripotency. Genes Dev 21:2671–2676. doi:10.1101/gad.1615707
Parker DS, Jemison J, Cadigan KM (2002) Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. Development 129:2565–2576
Polakis P (2000) Wnt signaling and cancer. Genes Dev 14:1837–1851
Popadiuk CM, Xiong J, Wells MG, Andrews PG, Dankwa K, Hirasawa K, Lake BB, Kao KR (2006) Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer. Clin Cancer Res 12:2216–2223. doi:10.1158/1078-0432.CCR-05-2433
Qiu B, Zhang D, Tao J, Wu A, Wang Y (2012) A simplified and modified procedure to culture brain glioma stem cells from clinical specimens. Oncol Lett 3:50–54. doi:10.3892/ol.2011.433
Shtutman M, Zhurinsky J, Simcha I, Albanese C, D’Amico M, Pestell R, Ben-Ze’ev A (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96:5522–5527
Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466. doi:10.1016/S1470-2045(09)70025-7
Thompson B, Townsley F, Rosin-Arbesfeld R, Musisi H, Bienz M (2002) A new nuclear component of the Wnt signalling pathway. Nat Cell Biol 4:367–373. doi:10.1038/ncb786
van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60:166–193. doi:10.3322/caac.20069
Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6:425–436. doi:10.1038/nrc1889
Wang ZX, Chen YY, Li BA, Tan GW, Liu XY, Shen SH, Zhu HW, Wang HD (2010) Decreased pygopus 2 expression suppresses glioblastoma U251 cell growth. J Neurooncol 100:31–41. doi:10.1007/s11060-010-0144-6
Watanabe K, Fallahi M, Dai X (2014) Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice. Oncogene 33:632–642. doi:10.1038/onc.2012.620
Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59–88. doi:10.1146/annurev.cellbio.14.1.59
Zhou SY, Xu ML, Wang SQ, Zhang F, Wang L, Wang HQ (2014) Overexpression of Pygopus-2 is required for canonical Wnt activation in human lung cancer. Oncol Lett 7:233–238. doi:10.3892/ol.2013.1691
Acknowledgments
This work was supported by the National Natural Science Foundation of China (no. 81271332) and Fujiani Natural Science Foundation (2009D002).
Conflict of Interest
All the authors of this study declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, M., Chao, L., Wu, J. et al. Pygo2 siRNA Inhibit the Growth and Increase Apoptosis of U251 Cell by Suppressing Histone H3K4 Trimethylation. J Mol Neurosci 56, 949–955 (2015). https://doi.org/10.1007/s12031-015-0558-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-015-0558-x